Star Metro - UniDoc Health Corp. Reflects on a Year of Growth and Innovation

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth sector, is proud to present its year in review, highlighting a series of achievements that underscore its progress toward transforming healthcare delivery. From partnerships to technological advancements, UniDoc has laid a foundation for continued growth and commercialization in 2025 and beyond.

Key Takeaways:

• Secured partnerships with industry leaders like HP Inc. and Carefluence to expand eHealth solutions globally.

• Transitioned to commercialization with multiple H3 Health Cube deployments in Europe.

• Launched NEIL Connect, an AI-driven software platform enhancing diagnostic precision and healthcare interoperability.

"2024 has been a pivotal year for UniDoc, marked by strategic collaborations and initial product sales," said Antonio Baldassarre, CEO of UniDoc Health Corp. "Our advancements reflect our commitment to enhancing healthcare accessibility and shareholder value. These achievements validate our vision of reshaping healthcare delivery through innovation and partnerships."

Expanding Global Reach Through Partnerships

UniDoc strengthened its position as a global eHealth innovator by forging partnerships with leading organizations. A strategic OEM agreement with HP Inc. enabled the integration and global distribution of HP products within UniDoc's H3 Health Cube platform. The collaboration resulted in UniDoc receiving its first purchase order from HP for 10 AI-equipped H3 Health Cubes, destined for deployment in Italian pharmacies across four regions.

Further enhancing its capabilities, UniDoc partnered with Carefluence to embed Fast Healthcare Interoperability Resources (FHIR) based interoperability into its telehealth solutions. This integration facilitates seamless data exchange across electronic health records (EHRs) and healthcare IT systems, improving care coordination and patient safety.

Advancing AI and Predictive Analytics

This year saw the launch of NEIL Connect, UniDoc's software platform designed to replicate in-person consultations. By integrating advanced diagnostic tools and secure communication technology, NEIL Connect aims to bridge the gap between traditional and virtual healthcare, enhancing diagnostic accuracy and patient outcomes.

In collaboration with DocBox Inc., UniDoc expanded its AI capabilities to be available for use in emergency room operations, introducing predictive analytics to manage non-urgent ER visits. These innovations aim to reduce overcrowding and improve patient care efficiency by predicting health declines and enabling proactive intervention.

Initial Product Deployments

UniDoc achieved initial product deployment milestones, including the shipment of its first AI-equipped H3 Health Cubes to commercial clients. These deployments included units for the Aiutamoli a Vivere Foundation in Italy, the Municipality of Aliano, and Ukraine's largest children's hospital, Okhmatdyt. These efforts are aiming to bring essential healthcare services to underserved and conflict-affected regions.

Recognition and Market Expansion

The Italian government designated UniDoc's H3 Health Cube as preferred equipment for eHealth initiatives in rural regions. This recognition led to an initial order from the Municipality of Aliano and established UniDoc as a preferred supplier for upcoming regional tenders.

Organizational Strengthening

To support its commercialization efforts, UniDoc welcomed Austin Thornberry as Chief Financial Officer. With a background in corporate finance and growth strategy, Mr. Thornberry's leadership strengthens UniDoc's financial foundation as it scales its operations.

Looking Ahead

"As UniDoc moves into 2025, we believe the Company is poised to build on this year's accomplishments. With a robust pipeline of innovations, partnerships, and deployments, UniDoc aims to continue delivering cutting-edge eHealth solutions that address global healthcare challenges," concludes Baldassarre.

On Behalf of the Board of Directors,

~Antonio Baldassarre~

Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.

About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)

UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.

For further information, please contact:

UniDoc Investor Relations
Tel: +1 778.383.6731
Email: [email protected]

Matt Chatterton, Director
Tel: +1 778.613.2082
Email: [email protected]

Media Inquiries [email protected]

Forward-Looking Statements

This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "will be", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the Company's expectation for continued growth and commercialization in 2025, the deployment of 10 H3 Health Cubes in pharmacies across four regions of Italy pursuant to HP's purchase order, the benefits the NEIL Connect® software will add to the Company's products, that the Company's products may be used in emergency room operations, and the Company's status as a preferred supplier for healthcare equipment in upcoming regional tenders for the Italian government.

Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company's ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company's annual management discussion and analysis dated July 31, 2024 under the heading "Risks Factors." Accordingly, readers should not place undue reliance on any such forward-looking information.

Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

SOURCE: UniDoc Health Corp.

S.Belanger--SMC